Briefing for the Diabetes Outcomes Versus Expenditure (DOVE) tool: Overview to 2018: Summary of results 2013 to 2018 – Public Health England

This report gives an overview of the tool and presents data from 2013/14 to 2017/18, showing how spend on diabetes medications and the proportion of patients achieving recommended blood glucose levels varies between general practices (GPs) and clinical commissioning groups

Trends In Life Expectancy In EU And Other OECD Countries: Why are improvements slowing? – Organisation for Economic Co-operation and Development

This paper reports on trends in life expectancy in the 28 EU countries and some other high-income OECD countries, and examines potential explanations for the slowdown in improvements in recent years. The slowdown in improvements in life expectancy since 2011

Transforming elective care services diabetes: Learning from the Elective Care Development Collaborative – NHS England and Nesta

This handbook describes what local health and care systems can do to transform diabetes elective care services at pace, why this is necessary and how the impact of this transformation can be measured. Practical guidance for implementing and adopting a range

Making hospitals safe for people with diabetes – Diabetes UK

Currently one in six hospital beds is occupied by someone with diabetes and by 2030 it is predicted this will rise to one in four. In hospital, people with diabetes have high infection rates, longer lengths of stay – one to three more

Neuropad for detecting preclinical diabetic peripheral neuropathy: Medical technologies guidance [MTG38] – NICE

The case for adopting Neuropad to detect preclinical diabetic peripheral neuropathy is not supported by the evidence. Neuropad detects sub-normal sweating in patients with diabetes but the clinical importance of this in current NHS care pathways is poorly defined. There

A new online resource to support and assist adults with Type 1 diabetes: letter from Dr Partha Kar – NHS England

This letter from Dr Partha Kar, NHS England Deputy National Clinical Director for Diabetes, highlights the online diabetes resource which provides practical information at diagnosis, such as videos on how to inject insulin, how to check blood glucose levels

Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours: Technology appraisal guidance [TA539] – NICE

Evidence-based recommendations on lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults. Lutetium (177Lu) oxodotreotide is recommended, within its marketing authorisation, as an option for treating unresectable or metastatic, progressive, well-differentiated (grade 1 or grade 2), somatostatin receptor-positive

Screening Quality Assurance Visit Report: NHS diabetic eye screening programme Aintree University Hospitals NHS Foundation Trust – Public Health England

The findings in this report relate to the quality assurance visit of the North Mersey diabetic eye screening service 18 January 2018. The QA visit team identified 3 high priority findings: a screening backlog in Southport and Ormskirk NHS Trust lack

Interventions to reduce emergency hospital admissions for diabetes : (Observatory Report Series number 80) – Liverpool University Public Health Observatory

Early treatment and intervention can greatly reduce the risk of complications and reduce health service expenditure, as well as improving quality of life for those with diabetes, so early intervention in this area is vital.  This report looks at interventions to reduce emergency

Uptake and retention in group-based weight-management services: Literature review and behavioural analysis – Public Health England

This review and behavioural analysis of group based weight management programmes, identifies the: main factors (barriers and facilitators) that affect whether people take up weight management programmes main factors (barriers and facilitators) influencing continued engagement with programmes components of programme

Screening Quality Assurance visit report: NHS Diabetic Eye Screening Programme North of Tyne & Gateshead – Public Health England

The findings in this report relate to the quality assurance (QA) visit of the NHS Diabetic Eye Screening Programme North of Tyne & Gateshead screening service held on 14 September 2017.  The QA visit team identified 1 high priority findings as

Language Matters: Language and diabetes – NHS England

This guide provides practical examples of language that will encourage positive interactions with people living with diabetes and subsequently positive outcomes.